| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Tadalafil | FAERS: 9 | US FAERS | |
| 2 | Octreotide | FAERS: 2 | US FAERS | |
| 3 | venetoclax | FAERS: 2 | US FAERS | |
| 4 | Atomoxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 5 | Clozapine | FAERS: 1 | US FAERS | |
| 6 | Finasteride | FAERS: 1 | US FAERS | |
| 7 | Lenalidomide | FAERS: 1 | US FAERS | |
| 8 | NuvaRing | FAERS: 1 | US FAERS | |
| 9 | Olanzapine | FAERS: 1 | US FAERS | |
| 10 | Oxymorphone | FAERS: 1 | US FAERS | |
| 11 | PCI 32765 | FAERS: 1 | US FAERS | |
| 12 | Solifenacin Succinate | FAERS: 1 | US FAERS | |
| 13 | Tamsulosin | FAERS: 1 | US FAERS | |
| 14 | empagliflozin | FAERS: 1 | US FAERS | |
| 15 | mirabegron | FAERS: 1 | US FAERS | |
| 16 | niraparib | FAERS: 1 | US FAERS | |
| 17 | pirfenidone | FAERS: 1 | US FAERS | |
| 18 | Octreotide | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.